Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Fragile X-Associated Tremor/ataxia Syndrome. Data from NIH RePORTER, last 36 months.
Fragile X-Associated Tremor/ataxia Syndrome has active NIH research funding with 15 funded grants totaling $16.3M.
3 new grants started in the last 12 months.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Fragile X-Associated Tremor/ataxia Syndrome. Strongest funded area: Basic Science. Largest gap: Clinical Research.
2 funded grants in Biomarker / Diagnostics but only 2 related publications found for fragile X-associated tremor/ataxia syndrome. This may indicate early-stage research that hasn't yet produced published results.
2 funded grants in Clinical Research but only 0 related publications found for fragile X-associated tremor/ataxia syndrome. This may indicate early-stage research that hasn't yet produced published results.
These grants mention Fragile X-Associated Tremor/ataxia Syndrome as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.